Colgate-Palmolive (CL) Earnings Analysis
Colgate-Palmolive (CL) next reports earnings on 2026-07-31, consensus EPS 0.947 USD. Last quarter (2026-05-01) it beat with EPS 0.97 USD vs 0.943 USD est (+2.9%). It has beaten estimates in 8/8 recent quarters (100%). Trailing P/E 35.32.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CL next report earnings?
| Next earnings date | 2026-07-31 |
|---|---|
| Consensus EPS estimate | 0.947 USD |
| Revenue estimate | 5.36B |
CL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-01 | 0.97 USD | 0.943 USD | +2.9% | Beat |
| 2026-01-30 | 0.95 USD | 0.912 USD | +4.2% | Beat |
| 2025-10-31 | 0.91 USD | 0.889 USD | +2.4% | Beat |
| 2025-08-01 | 0.92 USD | 0.897 USD | +2.6% | Beat |
| 2025-04-25 | 0.91 USD | 0.856 USD | +6.3% | Beat |
| 2025-01-31 | 0.91 USD | 0.9 USD | +1.1% | Beat |
| 2024-10-25 | 0.91 USD | 0.89 USD | +2.2% | Beat |
| 2024-07-26 | 0.91 USD | 0.87 USD | +4.6% | Beat |
Beat rate: 8/8 (100%) over reported quarters with consensus data.
CL valuation and analyst view
| Trailing P/E | 35.32 |
|---|---|
| Trailing EPS | 2.601 USD |
| Price / book | 507.00 |
| Dividend yield | 2.29% |
| Market cap | 73.43B |
| Analyst consensus | Hold (19 buy / 24 hold / 2 sell) |
| Avg price target | 97.5 USD |
Related research pages
Frequently asked questions
When is Colgate-Palmolive (CL)'s next earnings date?
Colgate-Palmolive is next scheduled to report on 2026-07-31, with a consensus EPS estimate of 0.947 USD and revenue estimate of 5.36B.
Did CL beat earnings last quarter?
In its 2026-05-01 report, CL posted EPS of 0.97 USD versus a 0.943 USD estimate — a beat of 2.9%.
What is CL's earnings track record?
Over the last 8 reported quarters with consensus data, CL beat estimates 8 times (100%).
What is CL's current P/E ratio and EPS?
CL trades at a trailing P/E of 35.32 on trailing EPS of 2.60127134488346 USD.
What do analysts rate CL?
Analyst consensus is "Hold" across 45 ratings (0 strong buy, 19 buy, 24 hold, 2 sell, 0 strong sell). Average 12-month price target: 97.5 USD.